Agile Therapeutics Inc (AGRX):企業の財務・戦略的SWOT分析

◆英語タイトル:Agile Therapeutics Inc (AGRX) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH139211FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥84,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥126,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Agile Therapeutics Inc (Agile) is a healthcare company that develops and commercializes prescription contraceptive products for women. The company provides contraceptive patch containing the active ingredients levonorgestrel and ethinyl estradiol and progestin-only birth control patch. Its pipeline product candidate include Twirla also known as AG200-15, a once-weekly prescription contraceptive patch designed using its skinfusion technology to deliver both hormones over a seven-day period. The company’s other hormonal contraceptive pipeline include AG200-SP, a novel regimen designed to allow women to experience shorter, lighter periods; AG200-ER, an extended cycle regimen that allows a woman to extend the time between her episodes of withdrawal bleeding, and AG890 a levonorgestrel-only contraceptive patch. Agile is headquartered in Princeton, New Jersey, the US.

Agile Therapeutics Inc Key Recent Developments

Mar 05,2021: Agile Therapeutics to Present at Upcoming March Investor Conferences
Mar 01,2021: Agile Therapeutics Reports Fourth Quarter & Full Year 2020 Financial Results
Feb 19,2021: Agile Therapeutics to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call and Provide Corporate and Twirla Commercial Updates on Monday, March 1, 2021
Jan 04,2021: Agile Therapeutics to Participate in Fireside Chat at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference
Nov 12,2020: Agile Therapeutics reports third quarter 2020 financial results

This comprehensive SWOT profile of Agile Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Agile Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Agile Therapeutics Inc – Key Information
Agile Therapeutics Inc – Overview
Agile Therapeutics Inc – Key Employees
Agile Therapeutics Inc – Key Employee Biographies
Agile Therapeutics Inc – Key Operational Heads
Agile Therapeutics Inc – Major Products and Services
Agile Therapeutics Inc – History
Agile Therapeutics Inc – Company Statement
Agile Therapeutics Inc – Locations And Subsidiaries
Agile Therapeutics Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Agile Therapeutics Inc – Business Description
Agile Therapeutics Inc – Corporate Strategy
Agile Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Agile Therapeutics Inc – Strengths
Agile Therapeutics Inc – Weaknesses
Agile Therapeutics Inc – Opportunities
Agile Therapeutics Inc – Threats
Agile Therapeutics Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Agile Therapeutics Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Agile Therapeutics Inc, Key Information
Agile Therapeutics Inc, Key Ratios
Agile Therapeutics Inc, Share Data
Agile Therapeutics Inc, Major Products and Services
Agile Therapeutics Inc, History
Agile Therapeutics Inc, Key Employees
Agile Therapeutics Inc, Key Employee Biographies
Agile Therapeutics Inc, Key Operational Heads
Agile Therapeutics Inc, Other Locations
Agile Therapeutics Inc, Subsidiaries
Agile Therapeutics Inc, Key Competitors
Agile Therapeutics Inc, SWOT Analysis
Agile Therapeutics Inc, Ratios based on current share price
Agile Therapeutics Inc, Annual Ratios
Agile Therapeutics Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Agile Therapeutics Inc (AGRX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • GarrettCom, Inc.:企業の戦略的SWOT分析
    GarrettCom, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • InspireMD Inc (NSPR)-医療機器分野:企業M&A・提携分析
    Summary InspireMD Inc (InspireMD), formerly Saguaro Resources Inc is a medical device company that develops and commercializes stent platform MGuard technology. The company’s products include carotid embolic prevention system, Mguard embolic prevention system and Mguard prime. Its MGuard is based on …
  • Florida Keys Electric Cooperative Association, Inc.:発電所・企業SWOT分析
    Florida Keys Electric Cooperative Association, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analys …
  • Banca Sella Holding SpA:企業の戦略的SWOT分析
    Banca Sella Holding SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Powerflute Oy:企業の戦略的SWOT分析
    Powerflute Oy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Martin Marietta Materials Inc:企業のM&A・事業提携・投資動向
    Martin Marietta Materials Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Martin Marietta Materials Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Reichhold LLC 2:企業の戦略的SWOT分析
    Reichhold LLC 2 - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Pioneer Corp:企業の戦略的SWOT分析
    Pioneer Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Jackson Electric Membership Corporation:発電所・企業SWOT分析
    Jackson Electric Membership Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informat …
  • AccorHotels:戦略・SWOT・企業財務分析
    AccorHotels - Strategy, SWOT and Corporate Finance Report Summary AccorHotels - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Enzymatica AB (ENZY):企業の財務・戦略的SWOT分析
    Summary Enzymatica AB (Enzymatica) is a life science company that develops and markets medical products for various virus and bacterial infections. The company offers mouth sprays and veterinary products. Its veterinary products comprise dental health and skin relief enzyme based gels, spray dermal …
  • Key Energy Services, Inc.:企業の戦略・SWOT・財務分析
    Key Energy Services, Inc. - Strategy, SWOT and Corporate Finance Report Summary Key Energy Services, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Jiangsu Expressway Co Ltd (600377):企業の財務・戦略的SWOT分析
    Summary Jiangsu Expressway Co Ltd (Jiangsu Expressway) is a highway development company that offers services in investment, construction, operation and management of toll expressways within Jiangsu province. The company offers services such as geographical services, service area development, express …
  • Copperbelt Energy Corporation PLC (CEC)-エネルギー分野:企業M&A・提携分析
    Summary Copperbelt Energy Corporation PLC (CEC) is an electric utility that generates, transmits, distributes and sells energy. The company generates electricity from hydro, solar, gas and thermal sources; transmits electricity through a network of transmission lines and high voltage substations and …
  • Adacel Technologies Ltd (ADA):企業の財務・戦略的SWOT分析
    Adacel Technologies Ltd (ADA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • InBios International Inc:企業の製品パイプライン分析
    Summary InBios International Inc (InBios International) is a medical device company that develops, manufactures and markets medical diagnostic tests for detecting infectious diseases. The company offers products such as assays, ELISA kits, rapid immunoassays, veterinary products, and monoclonal anti …
  • Pitney Bowes Inc (PBI):企業の財務・戦略的SWOT分析
    Pitney Bowes Inc (PBI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Acacia Research Corp:企業のM&A・事業提携・投資動向
    Acacia Research Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Acacia Research Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • National Mobile Telecommunications Company K.S.C.P.:企業の戦略・SWOT・財務情報
    National Mobile Telecommunications Company K.S.C.P. - Strategy, SWOT and Corporate Finance Report Summary National Mobile Telecommunications Company K.S.C.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's stru …
  • MediciNova Inc (MNOV):製薬・医療:M&Aディール及び事業提携情報
    Summary MediciNova Inc (MediciNova) focuses on acquiring, and developing novel, small-molecule therapeutics for the treatment of neurology, respiratory, and liver diseases. MediciNova’s developmental pipeline includes core programs for the treatment of fibrotic diseases; neurological disorders; and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆